Barrie Kellam

3.4k total citations
88 papers, 2.5k citations indexed

About

Barrie Kellam is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Barrie Kellam has authored 88 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 22 papers in Physiology and 19 papers in Cellular and Molecular Neuroscience. Recurrent topics in Barrie Kellam's work include Receptor Mechanisms and Signaling (39 papers), Adenosine and Purinergic Signaling (22 papers) and Pharmacological Receptor Mechanisms and Effects (16 papers). Barrie Kellam is often cited by papers focused on Receptor Mechanisms and Signaling (39 papers), Adenosine and Purinergic Signaling (22 papers) and Pharmacological Receptor Mechanisms and Effects (16 papers). Barrie Kellam collaborates with scholars based in United Kingdom, Australia and Netherlands. Barrie Kellam's co-authors include Stephen J. Hill, Stephen J. Briddon, Richard J. Middleton, Tracey D. Bradshaw, Maria Marlow, Marianne Ashford, Andrea J. Vernall, Leigh A. Stoddart, Kevin M. Shakesheff and Paul De Bank and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Scientific Reports.

In The Last Decade

Barrie Kellam

87 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barrie Kellam United Kingdom 29 1.7k 594 567 407 406 88 2.5k
Limin Ma China 12 1.2k 0.7× 515 0.9× 210 0.4× 194 0.5× 336 0.8× 16 2.3k
Míriam Royo Spain 29 2.3k 1.3× 250 0.4× 1.0k 1.8× 71 0.2× 319 0.8× 146 3.2k
Barbara Cacciari Italy 31 1.6k 0.9× 588 1.0× 1.3k 2.3× 1.3k 3.1× 115 0.3× 108 3.1k
Cristina Marchini Italy 34 1.8k 1.0× 249 0.4× 176 0.3× 112 0.3× 373 0.9× 87 2.9k
Josef Vágner United States 32 2.0k 1.2× 380 0.6× 794 1.4× 32 0.1× 185 0.5× 97 3.1k
Hyun‐Woo Rhee South Korea 29 2.9k 1.7× 198 0.3× 903 1.6× 51 0.1× 193 0.5× 82 4.5k
Michael Wright United Kingdom 25 1.1k 0.6× 82 0.1× 203 0.4× 89 0.2× 167 0.4× 80 2.0k
Timothy A. Hill Australia 28 1.9k 1.1× 139 0.2× 821 1.4× 49 0.1× 172 0.4× 66 2.7k
Meritxell Teixidò Spain 29 1.8k 1.0× 191 0.3× 269 0.5× 23 0.1× 621 1.5× 80 2.8k
Marc Devocelle Ireland 29 1.3k 0.8× 149 0.3× 448 0.8× 32 0.1× 149 0.4× 83 2.4k

Countries citing papers authored by Barrie Kellam

Since Specialization
Citations

This map shows the geographic impact of Barrie Kellam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barrie Kellam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barrie Kellam more than expected).

Fields of papers citing papers by Barrie Kellam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barrie Kellam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barrie Kellam. The network helps show where Barrie Kellam may publish in the future.

Co-authorship network of co-authors of Barrie Kellam

This figure shows the co-authorship network connecting the top 25 collaborators of Barrie Kellam. A scholar is included among the top collaborators of Barrie Kellam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barrie Kellam. Barrie Kellam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, Carl W., Laura E. Kilpatrick, Nicholas D. Kindon, et al.. (2024). CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science Signaling. 17(828). eabl3758–eabl3758. 10 indexed citations
2.
Soukarieh, Fadi, William Richardson, Manuel Romero, et al.. (2024). Design, Synthesis, and Evaluation of New 1H-Benzo[d]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of Medicinal Chemistry. 67(2). 1008–1023. 5 indexed citations
3.
Goulding, Joëlle, Marleen Groenen, Jeanette Woolard, et al.. (2024). Ligand-Directed Labeling of the Adenosine A1 Receptor in Living Cells. Journal of Medicinal Chemistry. 67(14). 12099–12117. 2 indexed citations
4.
Goulding, Joëlle, Nicholas D. Kindon, Laura E. Kilpatrick, et al.. (2023). Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor. Journal of Medicinal Chemistry. 66(7). 5208–5222. 7 indexed citations
5.
Jooss, Natalie J., Mark R. Thomas, Natalie S. Poulter, et al.. (2023). Characterizing the binding of glycoprotein VI with nanobody 35 reveals a novel monomeric structure of glycoprotein VI where the conformation of D1+D2 is independent of dimerization. Journal of Thrombosis and Haemostasis. 21(2). 317–328. 6 indexed citations
6.
Arimont, Marta, Meritxell Canals, Chris de Graaf, et al.. (2023). Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3). ACS Medicinal Chemistry Letters. 15(1). 143–148. 3 indexed citations
7.
Stoddart, Leigh A., Laura E. Kilpatrick, Ross Corriden, et al.. (2021). Efficient G protein coupling is not required for agonist‐mediated internalization and membrane reorganization of the adenosine A 3 receptor. The FASEB Journal. 35(4). e21211–e21211. 3 indexed citations
8.
Nguyen, Thi, Cameron J. Nowell, Nicholas D. Kindon, et al.. (2021). Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells. Journal of Medicinal Chemistry. 64(10). 6670–6695. 11 indexed citations
9.
Soukarieh, Fadi, William Richardson, Manuel Romero, et al.. (2021). Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa. ACS Infectious Diseases. 7(9). 2666–2685. 28 indexed citations
10.
Goulding, Joëlle, Mark Soave, Jeanette Woolard, et al.. (2021). Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels. Pharmacology Research & Perspectives. 9(3). e00779–e00779. 7 indexed citations
11.
Soave, Mark, Raimond Heukers, Barrie Kellam, et al.. (2020). Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies. Cell chemical biology. 27(10). 1250–1261.e5. 22 indexed citations
12.
Baker, Jillian G., Christophe Fromont, Kevin S. J. Thompson, et al.. (2020). Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers. ACS Pharmacology & Translational Science. 3(4). 737–748. 4 indexed citations
13.
Soave, Mark, Barrie Kellam, Jeanette Woolard, Stephen J. Briddon, & Stephen J. Hill. (2019). NanoBiT Complementation to Monitor Agonist-Induced Adenosine A1 Receptor Internalization. SLAS DISCOVERY. 25(2). 186–194. 28 indexed citations
14.
Kellam, Barrie, David A. Sykes, Ben Capuano, et al.. (2019). Structure–Kinetic Profiling of Haloperidol Analogues at the Human Dopamine D2 Receptor. Journal of Medicinal Chemistry. 62(21). 9488–9520. 15 indexed citations
15.
Kindon, Nicholas D., Mark Soave, Leigh A. Stoddart, et al.. (2019). Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A2A Receptor. Journal of Medicinal Chemistry. 63(5). 2656–2672. 25 indexed citations
16.
Zarzycka, Barbara, Herman D. Lim, Barrie Kellam, et al.. (2018). A Thieno[2,3-d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D2 Receptor. Journal of Medicinal Chemistry. 62(1). 174–206. 23 indexed citations
17.
Stoddart, Leigh A., Andrea J. Vernall, Reggie Bosma, et al.. (2018). Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells. Scientific Reports. 8(1). 1572–1572. 51 indexed citations
18.
Kindon, Nicholas D., Jacqueline R. Glenn, Leigh A. Stoddart, et al.. (2018). Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925. Journal of Medicinal Chemistry. 61(7). 3089–3113. 24 indexed citations
19.
Gondin, Arisbel B., Meritxell Canals, Barrie Kellam, et al.. (2018). Fluorescently Labeled Morphine Derivatives for Bioimaging Studies. Journal of Medicinal Chemistry. 61(3). 1316–1329. 23 indexed citations
20.
Corriden, Ross, Tim Self, Victor Nizet, et al.. (2013). Adenosine‐A 3 receptors in neutrophil microdomains promote the formation of bacteria‐tethering cytonemes. EMBO Reports. 14(8). 726–732. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026